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The prevalence of asthma has been reported to range from 1 to
18% of the population in different countries.1 This means that
several hundred million patients with asthma rely on the efficacy of
their inhalers to achieve asthma control. Undeniably, inhaled therapy
remains the cornerstone of treatment for patients with asthma, and
the main inhalation devices used are pressurised metered dose
inhalers (pMDIs) and dry powder inhalers (DPIs).2 Yet there are more
than 200 different drug-inhaler combinations available in any
medical formulary, and this causes immense confusion amongst
prescribers, healthcare professionals and patients.     
Published evidence shows that, when used correctly, there is little
difference in clinical efficacy between different inhaler types.3
However, several studies have reported that a high proportion of
patients cannot use their inhalers (either pMDIs or DPIs) well enough
to benefit from the treatment.4,5 These numbers are even more
depressing considering that between 40 to 85% of healthcare
professionals, who should readily be able to teach patients how to use
their inhalers correctly, do not seem to be able to perform that task
properly – and doctors are the worst amongst all healthcare
professionals.6-8
It has clearly been shown that failure to use inhalers correctly may
result in poor asthma control,8 increased cost,9 and a greater risk to the
patient from exposure to less well-tolerated alternative treatments. In
a large cross-sectional study involving over 1600 asthma outpatients,
the finding of just one critical error in inhalation technique, irrespective
of the inhalation device (DPI or pMDI), was associated with increased
emergency room visits, hospitalisation and oral medication
prescription.10
In this issue of the PCRJ, Levy and co-workers11 retrospectively
evaluated pMDIs usage in a large cohort (nearly 4000) of UK primary
care patients with asthma, and correlated patients’ inhaler technique
with the level of asthma control. Patients at British Thoracic Society
(BTS) treatment steps 1, 2 and 3 had their asthma status reviewed
through the Improving the Management of Patients Asthma and
COPD Treatment (IMPACT) service, where specialist nurse advisors
undertake asthma reviews in primary care according to protocols
based on the UK BTS/SIGN National Asthma Guidelines.12 Interestingly,
part of the review involved evaluating pMDI inhaler technique
objectively by using the Vitalograph Aerosol Inhalation Monitor,13 a
training device aimed at assessing three crucial steps needed for
correct pMDI usage: slow inhalation flow (below 50 L/min);
synchronisation between inhaler actuation and inhalation; and a 5
second breath-hold pause following inhalation.
The authors observed that patients who displayed significant
errors when using pMDIs had higher risks of poor asthma control and
more bursts of systemic corticosteroid prescriptions than those who
operated pMDIs correctly.11 Of note, patients who were using pMDIs
in conjunction with spacers, or were using breath-actuated inhalers,
had better asthma control than those using pMDIs alone.
Synchronisation – i.e. achieving the correct inhalation flow following
actuation – was the main step in the inhalation technique which most
patients failed.
These findings should be interpreted in the context of the
retrospective observational nature of the study. We do not know
whether other reasons for poor disease control (e.g. co-morbidities,
different treatment plans, different drug dosages) were more frequent
in patients who misused their pMDI than those who used it correctly.
In addition, the UK is rather atypical with respect to device prescription
compared to the rest of Europe, where DPIs are the favoured
inhalation device. In this current study, only 9% and 14% of patients,
respectively, used their DPI as reliever, or maintenance, therapy. The
investigators did not attempt to assess inhalation technique in the
patients prescribed a DPI, nor did they relate DPI technique to asthma
control. Certainly there is evidence to show that patients using DPIs
may experience more critical errors than those using pMDIs.10 Despite
these limitations, the results of the study by Levy et al. are important:
they confirm the relationship between inhaler misuse and poor
asthma control, and reinforce the notion of the importance of patients
training for efficient inhalation drug delivery.11
Patients’ ability to handle inhalers correctly is a crucial issue for the
choice of the most appropriate inhaler device for a given patient.
Adherence to therapy is likely to be influenced by patients’ attitudes
and their experience in using the device, and if the patient feels that
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their treatment is not working, adherence is likely to be poor with
consequently reduced efficacy of treatment. Sometimes incorrect use
of inhalers is not simply due to patients’ lack of competence, but also
to deliberate non-adherence by patients (‘contrivance’) who use their
inhalers incorrectly.9
Despite the development of several new and improved types of
inhaler device, there has been no sustained improvement over the
past 35 years in patients’ ability to use their inhalers.4 The mantra for
how to get patients to use inhalers correctly has been, and still seems
to be: “training and more training”.2 Evidence shows that patients’
competence in self-administration of inhaled medications is improved
by educational interventions,14 and repeated training in correct inhaler
use improves asthma symptoms,15 quality of life,16 lung function,17 and
reduces the use of reliever medications as well as emergency hospital
admissions.18
We advocate that choosing an inhalation device for drug
administration in patients with obstructive airway diseases is as critical
as the choice of medication itself, and that in future, the choice of a
new compound will be secondary to the need to choose the
appropriate inhaler device for the patient.19
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